nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiludronate—PTPN1—embryo—liver cancer	0.0174	0.428	CbGeAlD
Tiludronate—ATP6V1A—embryo—liver cancer	0.0104	0.256	CbGeAlD
Tiludronate—PTPN1—liver—liver cancer	0.00804	0.198	CbGeAlD
Tiludronate—ATP6V1A—liver—liver cancer	0.00482	0.118	CbGeAlD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00408	0.00425	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00408	0.00425	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—MAPK8—liver cancer	0.00408	0.00425	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—CTNNB1—liver cancer	0.00406	0.00423	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CD81—liver cancer	0.004	0.00417	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PRKCE—liver cancer	0.00399	0.00416	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—PIK3CA—liver cancer	0.00394	0.00411	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—BRAF—liver cancer	0.00393	0.0041	CbGpPWpGaD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—liver cancer	0.00389	0.00405	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—MAPK8—liver cancer	0.00387	0.00404	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—NR1H4—liver cancer	0.00386	0.00402	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—IGF2—liver cancer	0.00378	0.00394	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IFNA1—liver cancer	0.00373	0.00389	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—STAT3—liver cancer	0.00373	0.00389	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—MAPK14—liver cancer	0.0037	0.00386	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Pathway—AKT1—liver cancer	0.00361	0.00377	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—HGF—liver cancer	0.00357	0.00372	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—CSF2—liver cancer	0.00353	0.00368	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—RAF1—liver cancer	0.00349	0.00363	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—PIK3CG—liver cancer	0.00343	0.00358	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—MTOR—liver cancer	0.0034	0.00355	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—PIK3CB—liver cancer	0.0034	0.00355	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—RAF1—liver cancer	0.00328	0.00342	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—SRMS—liver cancer	0.00326	0.0034	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—AKT1—liver cancer	0.00322	0.00336	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—PIK3CB—liver cancer	0.00321	0.00334	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—SERPINA1—liver cancer	0.00312	0.00326	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CHN2—liver cancer	0.00304	0.00317	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CHN2—liver cancer	0.00304	0.00317	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—PIK3CD—liver cancer	0.00302	0.00315	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—HGF—liver cancer	0.00296	0.00308	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—CSF2—liver cancer	0.00292	0.00305	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—JUN—liver cancer	0.00286	0.00298	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—MAPK14—liver cancer	0.00286	0.00298	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—PIK3CA—liver cancer	0.00279	0.00291	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IFT88—liver cancer	0.00278	0.0029	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IFT88—liver cancer	0.00278	0.0029	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—F2—liver cancer	0.00277	0.00289	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—HRAS—liver cancer	0.00272	0.00284	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—MAPK8—liver cancer	0.00271	0.00282	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—RAF1—liver cancer	0.00269	0.00281	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PIK3CG—liver cancer	0.00265	0.00276	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—PIK3CB—liver cancer	0.00263	0.00274	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—MTOR—liver cancer	0.00263	0.00274	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—liver cancer	0.00258	0.00269	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—STAT3—liver cancer	0.00248	0.00258	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—AKT1—liver cancer	0.0024	0.0025	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—JUN—liver cancer	0.00235	0.00245	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	0.00233	0.00243	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—IFNA1—liver cancer	0.00233	0.00242	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	0.00231	0.0024	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—MYC—liver cancer	0.0023	0.0024	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—ALB—liver cancer	0.0023	0.0024	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—liver cancer	0.00228	0.00238	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—KRAS—liver cancer	0.00226	0.00235	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—LTF—liver cancer	0.00224	0.00233	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—MAPK8—liver cancer	0.00222	0.00232	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—KRAS—liver cancer	0.00213	0.00222	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—RAF1—liver cancer	0.00208	0.00217	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—PIK3CA—liver cancer	0.00207	0.00216	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PRKCE—liver cancer	0.00206	0.00214	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	0.00203	0.00212	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—CYCS—liver cancer	0.00197	0.00205	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—ABL1—liver cancer	0.00196	0.00204	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—PIK3CA—liver cancer	0.00195	0.00204	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—IGF2—liver cancer	0.00195	0.00203	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—PIK3CD—liver cancer	0.00193	0.00201	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—HRAS—liver cancer	0.00192	0.002	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—IL2—liver cancer	0.00187	0.00194	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—HGF—liver cancer	0.00184	0.00192	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—IL6—liver cancer	0.00184	0.00191	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—CSF2—liver cancer	0.00182	0.0019	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—HRAS—liver cancer	0.00181	0.00188	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ALDOB—liver cancer	0.00173	0.0018	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—RAF1—liver cancer	0.00172	0.0018	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—HMOX1—liver cancer	0.00171	0.00178	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SHC3—liver cancer	0.00171	0.00178	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SHC3—liver cancer	0.00171	0.00178	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—PIK3CB—liver cancer	0.00168	0.00175	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—PIK3CA—liver cancer	0.0016	0.00167	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—VEGFA—liver cancer	0.00159	0.00165	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL2—liver cancer	0.00154	0.00161	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—HRAS—liver cancer	0.00148	0.00155	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ADAM17—liver cancer	0.00148	0.00154	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—MAPK14—liver cancer	0.00147	0.00154	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—TGFB1—liver cancer	0.00146	0.00152	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—F2—liver cancer	0.00143	0.00149	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PSMA4—liver cancer	0.00139	0.00145	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PSMD10—liver cancer	0.00139	0.00145	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—PPARA—liver cancer	0.00138	0.00144	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ADAM17—liver cancer	0.00137	0.00143	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3CG—liver cancer	0.00137	0.00142	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FST—liver cancer	0.00132	0.00138	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FST—liver cancer	0.00132	0.00138	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—AKT1—liver cancer	0.00131	0.00137	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—STAT3—liver cancer	0.0013	0.00135	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PSMA4—liver cancer	0.00129	0.00134	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PSMD10—liver cancer	0.00129	0.00134	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TRIO—liver cancer	0.00126	0.00132	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TRIO—liver cancer	0.00126	0.00132	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—GOT2—liver cancer	0.00125	0.0013	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	0.00124	0.00129	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IFNA1—liver cancer	0.00122	0.00127	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCR4—liver cancer	0.00121	0.00126	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCR4—liver cancer	0.00121	0.00126	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3CD—liver cancer	0.0012	0.00125	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—SERPINE1—liver cancer	0.00119	0.00124	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—ALB—liver cancer	0.00119	0.00124	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—KRAS—liver cancer	0.00112	0.00116	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—GOT1—liver cancer	0.00108	0.00113	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PRKCE—liver cancer	0.00108	0.00112	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—RAF1—liver cancer	0.00107	0.00112	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3CB—liver cancer	0.00105	0.00109	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—ALB—liver cancer	0.00103	0.00107	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ABL1—liver cancer	0.00103	0.00107	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—PIK3CA—liver cancer	0.00102	0.00107	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—AKT1—liver cancer	0.00101	0.00105	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PRKCE—liver cancer	0.000996	0.00104	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—HGF—liver cancer	0.000965	0.00101	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—IL2—liver cancer	0.000962	0.001	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ADAM17—liver cancer	0.000958	0.000998	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ADAM17—liver cancer	0.000958	0.000998	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CD8A—liver cancer	0.000954	0.000995	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CSF2—liver cancer	0.000954	0.000995	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—HRAS—liver cancer	0.000948	0.000988	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—RAF1—liver cancer	0.000929	0.000968	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL6—liver cancer	0.000908	0.000946	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PSMA4—liver cancer	0.0009	0.000938	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PSMD10—liver cancer	0.0009	0.000938	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PSMA4—liver cancer	0.0009	0.000938	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PSMD10—liver cancer	0.0009	0.000938	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—H2AFX—liver cancer	0.000868	0.000905	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—VEGFA—liver cancer	0.000817	0.000852	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BCL2L1—liver cancer	0.000817	0.000851	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MTHFR—liver cancer	0.000788	0.000821	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TERT—liver cancer	0.000785	0.000819	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAPK14—liver cancer	0.000773	0.000806	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TGFB1—liver cancer	0.00075	0.000782	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PRKCE—liver cancer	0.000697	0.000727	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PRKCE—liver cancer	0.000697	0.000727	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—KRAS—liver cancer	0.000695	0.000724	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APC—liver cancer	0.000662	0.00069	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IGF2—liver cancer	0.000661	0.000689	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IGF2—liver cancer	0.000661	0.000689	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDH1—liver cancer	0.00066	0.000688	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3CA—liver cancer	0.000638	0.000665	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CD—liver cancer	0.00063	0.000657	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—BRAF—liver cancer	0.000622	0.000648	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TP53—liver cancer	0.000618	0.000644	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CSF2—liver cancer	0.000617	0.000643	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CSF2—liver cancer	0.000617	0.000643	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—H2AFX—liver cancer	0.000608	0.000634	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—H2AFX—liver cancer	0.000608	0.000634	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—HRAS—liver cancer	0.000591	0.000616	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CD—liver cancer	0.000582	0.000606	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SERPINE1—liver cancer	0.000575	0.0006	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—RAF1—liver cancer	0.000562	0.000586	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TERT—liver cancer	0.00055	0.000573	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TERT—liver cancer	0.00055	0.000573	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MTOR—liver cancer	0.000549	0.000572	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CB—liver cancer	0.000549	0.000572	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—AKT1—liver cancer	0.000522	0.000544	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—RAF1—liver cancer	0.000519	0.000541	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDKN1B—liver cancer	0.000515	0.000537	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CB—liver cancer	0.000507	0.000529	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MTOR—liver cancer	0.000507	0.000529	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL2—liver cancer	0.000504	0.000526	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KDR—liver cancer	0.000503	0.000524	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KDR—liver cancer	0.000503	0.000524	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAPK14—liver cancer	0.0005	0.000521	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAPK14—liver cancer	0.0005	0.000521	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—JUN—liver cancer	0.000491	0.000511	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ESR1—liver cancer	0.00049	0.000511	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ESR1—liver cancer	0.00049	0.000511	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CTNNB1—liver cancer	0.000487	0.000508	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—F2—liver cancer	0.000484	0.000505	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—F2—liver cancer	0.000484	0.000505	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CDKN1B—liver cancer	0.000476	0.000496	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDKN1A—liver cancer	0.000476	0.000496	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAPK8—liver cancer	0.000464	0.000484	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CG—liver cancer	0.000463	0.000483	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APC—liver cancer	0.000463	0.000483	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CG—liver cancer	0.000463	0.000483	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APC—liver cancer	0.000463	0.000483	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CTNNB1—liver cancer	0.00045	0.000469	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CDKN1A—liver cancer	0.000439	0.000458	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—BRAF—liver cancer	0.000436	0.000454	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—BRAF—liver cancer	0.000436	0.000454	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—STAT3—liver cancer	0.000424	0.000442	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CD—liver cancer	0.000407	0.000425	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CD—liver cancer	0.000407	0.000425	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SERPINE1—liver cancer	0.000403	0.00042	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SERPINE1—liver cancer	0.000403	0.00042	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—STAT3—liver cancer	0.000392	0.000408	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—KRAS—liver cancer	0.000364	0.00038	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MYC—liver cancer	0.000364	0.00038	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—RAF1—liver cancer	0.000364	0.000379	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RAF1—liver cancer	0.000364	0.000379	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TGFB1—liver cancer	0.000363	0.000379	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MTOR—liver cancer	0.000355	0.00037	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CB—liver cancer	0.000355	0.00037	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CB—liver cancer	0.000355	0.00037	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MTOR—liver cancer	0.000355	0.00037	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—KRAS—liver cancer	0.000336	0.000351	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CA—liver cancer	0.000335	0.000349	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CDKN1B—liver cancer	0.000333	0.000347	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CDKN1B—liver cancer	0.000333	0.000347	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CASP3—liver cancer	0.000327	0.00034	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CASP3—liver cancer	0.000327	0.00034	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL2—liver cancer	0.000326	0.00034	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL2—liver cancer	0.000326	0.00034	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCND1—liver cancer	0.000318	0.000331	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCND1—liver cancer	0.000318	0.000331	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—JUN—liver cancer	0.000317	0.000331	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—JUN—liver cancer	0.000317	0.000331	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CTNNB1—liver cancer	0.000315	0.000328	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CTNNB1—liver cancer	0.000315	0.000328	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—HRAS—liver cancer	0.00031	0.000323	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CA—liver cancer	0.000309	0.000322	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MMP9—liver cancer	0.000309	0.000322	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MMP9—liver cancer	0.000309	0.000322	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CDKN1A—liver cancer	0.000307	0.000321	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CDKN1A—liver cancer	0.000307	0.000321	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAPK8—liver cancer	0.0003	0.000313	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAPK8—liver cancer	0.0003	0.000313	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL6—liver cancer	0.000296	0.000309	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HRAS—liver cancer	0.000286	0.000298	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VEGFA—liver cancer	0.000277	0.000289	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VEGFA—liver cancer	0.000277	0.000289	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—STAT3—liver cancer	0.000274	0.000286	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—STAT3—liver cancer	0.000274	0.000286	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IL6—liver cancer	0.000274	0.000285	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—AKT1—liver cancer	0.000273	0.000285	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MYC—liver cancer	0.000255	0.000266	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MYC—liver cancer	0.000255	0.000266	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TGFB1—liver cancer	0.000254	0.000265	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TGFB1—liver cancer	0.000254	0.000265	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—AKT1—liver cancer	0.000252	0.000263	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KRAS—liver cancer	0.000236	0.000246	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KRAS—liver cancer	0.000236	0.000246	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CA—liver cancer	0.000216	0.000226	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CA—liver cancer	0.000216	0.000226	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TP53—liver cancer	0.000209	0.000218	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TP53—liver cancer	0.000209	0.000218	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HRAS—liver cancer	0.0002	0.000209	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HRAS—liver cancer	0.0002	0.000209	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL6—liver cancer	0.000192	0.0002	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL6—liver cancer	0.000192	0.0002	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AKT1—liver cancer	0.000177	0.000184	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AKT1—liver cancer	0.000177	0.000184	CbGpPWpGaD
